155 related articles for article (PubMed ID: 3673236)
1. [Pharmacodynamics, pharmacokinetics and side effects of cardiac glycosides].
Sivkov II; Kukes VG; Ibadova DN; Shokhor VIa; Otdelenov AV
Vestn Akad Med Nauk SSSR; 1987; (9):83-7. PubMed ID: 3673236
[No Abstract] [Full Text] [Related]
2. [Peculiarities of cardiac glycoside therapy in the aged].
Erdmann E
Internist (Berl); 1991 Aug; 32(8):472-8. PubMed ID: 1938268
[No Abstract] [Full Text] [Related]
3. [Cardiac glycosides and uremia].
Hevendehl G; Hennemann H; Vaitl F; Heidland A
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1672-5. PubMed ID: 1030076
[No Abstract] [Full Text] [Related]
4. [Indications, contra-indications and dosage of cardiac glycosides controlled by plasma levels in the aged].
Hötter GJ
Z Gerontol; 1987; 20(1):8-12. PubMed ID: 3577317
[TBL] [Abstract][Full Text] [Related]
5. [Indications and contraindications for therapy with cardiac glycosides].
Haasis R
Fortschr Med; 1982 Aug; 100(31-32):1436-9. PubMed ID: 7129303
[TBL] [Abstract][Full Text] [Related]
6. [Current data on the role of cardiac glycosides in the treatment of circulatory insufficiency].
Valenkevich LN; Lemkina SM
Klin Med (Mosk); 1989 Jan; 67(1):18-23. PubMed ID: 2654460
[No Abstract] [Full Text] [Related]
7. [Action mechanism of cardioactive glycosides in pathophysiologic conditions].
Bolte HD
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():19-27. PubMed ID: 611942
[No Abstract] [Full Text] [Related]
8. [Choice of digitalis glycosides].
Clément D
Ther Umsch; 1970 Mar; 27(3):181-4. PubMed ID: 5437616
[No Abstract] [Full Text] [Related]
9. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
Gold H; Kwit NT; Shane SJ; Dayrit C
J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
[No Abstract] [Full Text] [Related]
10. [Treatment of heart failure, with special consideration of iatrogenic complications].
Lüderitz B; Avenhaus H
Munch Med Wochenschr; 1970 Oct; 112(40):1779-84. PubMed ID: 5536213
[No Abstract] [Full Text] [Related]
11. [Cardiac glycoside therapy].
Born H
Folia Clin Int (Barc); 1969 Nov; 17(11):534-45. PubMed ID: 5803723
[No Abstract] [Full Text] [Related]
12. [Quantitative studies on the therapeutic range of cardiac glycosides].
Diederen W; Kadatz R
Arztl Forsch; 1970 May; 24(5):149-55. PubMed ID: 5538016
[No Abstract] [Full Text] [Related]
13. Congestive heart failure and cardiogenic shock - drug therapy.
Kitchen I
Nursing (Lond); 1984 May; 2(25):743-5. PubMed ID: 6563465
[No Abstract] [Full Text] [Related]
14. [Clinical evaluation of the cardiotonic effects of proscilaridine].
Netto MP; Forti N; Formicola A; Chryssovergis G; Zillioto EE; Campanari JC; Lunardi W; Giannini SD
Rev Hosp Clin Fac Med Sao Paulo; 1973; 28(6):300-4. PubMed ID: 4767562
[No Abstract] [Full Text] [Related]
15. [Experiences with the cardiac glycoside Proscillaridin A (Sandoscill)].
Amirfallah A; Einert HJ
Munch Med Wochenschr; 1967 Aug; 109(33):1690-2. PubMed ID: 5631640
[No Abstract] [Full Text] [Related]
16. [Cardiac glycoside therapy].
Michel D
Fortschr Med; 1971 Aug; 89(24):917-21. PubMed ID: 4262966
[No Abstract] [Full Text] [Related]
17. [The importance of cardiac glycoside therapy. Digitalis--to use or not to use?].
Jerie P
Ther Umsch; 1984 Feb; 41(2):96-102. PubMed ID: 6369617
[No Abstract] [Full Text] [Related]
18. [Principles and directives for practical treatment with cardiac glycosides].
Dörffel EF
Z Arztl Fortbild (Jena); 1971 Mar; 65(5):237-44. PubMed ID: 4997296
[No Abstract] [Full Text] [Related]
19. [Clinical experience with the cardiac glycoside Gitoformat (author's transl)].
Benda L; Zenz W
Med Klin; 1978 Jul; 73(30):1081-4. PubMed ID: 672762
[TBL] [Abstract][Full Text] [Related]
20. [Introduction to clinical pharmacodynamics and pharmacokinetics of cardiac glycosides].
Kudrin AN; Namakanov BA; Davydova ON
Sov Med; 1981; (11):70-4. PubMed ID: 7038899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
